Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID)

ClinicalTrials.gov ID: NCT04405739

Public ClinicalTrials.gov record NCT04405739. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Safety of EIDD-2801 and Its Effect on Viral Shedding of SARS-CoV-2

Study identification

NCT ID
NCT04405739
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ridgeback Biotherapeutics, LP
Industry
Enrollment
71 participants

Conditions and interventions

Conditions

Interventions

  • EIDD-2801 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 15, 2020
Primary completion
Feb 20, 2022
Completion
Feb 20, 2022
Last update posted
Mar 22, 2023

2020 – 2022

United States locations

U.S. sites
11
U.S. states
7
U.S. cities
10
Facility City State ZIP Site status
Ronald Reagan UCLA Medical Center Los Angeles California 90095-8358
Cook County Hospital Chicago Illinois 60612
Advocate Christ Medical Center Oak Lawn Illinois 60453
Advocate Lutheran General Hospital Park Ridge Illinois 60068
Ochsner LSU Health Shreveport Academic Medical Center Shreveport Louisiana 71101
Johns Hopkins Bayview Medical Center Baltimore Maryland 21224
John Hopkins Hospital Baltimore Maryland 21287
Howard County General Hospital Columbia Maryland 21044
Wake Forest Baptist Health Winston-Salem North Carolina 27157
Vanderbilt University Nashville Tennessee 37235
Houston Methodist Hospital Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04405739, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 22, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04405739 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →